Refine your search
Collections
Co-Authors
Journals
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Chhajed, Santosh
- Development and Validation of RP-HPLC Method for Simultaneous Estimation of Metformin HCl and Gliclazide
Abstract Views :200 |
PDF Views:6
Authors
Affiliations
1 Department of Pharmaceutical Analysis, MET’s Institute of Pharmacy, Bhujbal Knowledge City, Adgaon, Nashik – 422 003, IN
1 Department of Pharmaceutical Analysis, MET’s Institute of Pharmacy, Bhujbal Knowledge City, Adgaon, Nashik – 422 003, IN
Source
Asian Journal of Pharmaceutical Analysis, Vol 6, No 3 (2016), Pagination: 151-154Abstract
A new, simple and validated RP-HPLC method was developed for simultaneous estimation of MetforminHCl (MET) and Gliclazide (GLZ).The separation was achieved by using mobile phase Methanol: 10 mM Phosphate buffer (pH 3) 70:30 % v/v on Kinetics C18 column (250 x 4.6 mm, 5μ). The flow rate was 1 ml/min. The detection was carried out at wavelength 230 nm.The retention time of MET and GLZ was found to be 2.20 min and 4.67 min, respectively. Calibration curves for MET and GLZ were found to be linear in the range of 10-60 μg/ml and 2-12 μg/ml, respectively. The proposed method was validated as per ICH guideline Q2 (R1). The validation parameters studied were linearity, accuracy, precision, specificity and robustness. All validation parameters were found within the acceptable range.Keywords
Metformin HCl, Gliclazide, RP-HPLC, Analytical Method Validation.
- Development and Validation of RP-HPLC Method for Simultaneous Estimation of Telmisartan, Amlodipine Besylate and Hydrochlorthiazide in their Tablet Dosage Form
Abstract Views :220 |
PDF Views:0
Authors
Affiliations
1 MET’s Institute of Pharmacy, Bhujbal Knowledge City, Adgaon, Nashik – 422 003, IN
1 MET’s Institute of Pharmacy, Bhujbal Knowledge City, Adgaon, Nashik – 422 003, IN
Source
Asian Journal of Pharmaceutical Analysis, Vol 7, No 3 (2017), Pagination: 189-195Abstract
To treat the second stage high blood pressure, physicians prefers the combination drug therapy consisting of two or more anti-hypertensive agents. Among these, telmisartan with amlodipine besylate, telmisartan with hydrochlorthiazide as well as triple drug therapy consisting of amlodipine besylate, telmisartan and hydrochlorthiazide are commonly prescribed. In the present paper, a simple, accurate and precise RP-HPLC method was developed for the estimation of amlodipine besylate, telmisartan and hydrochlorthiazide in bulk and combined dosage form. All these three drugs were successfully separated and resolved from each other on C18 kinetex column (250 × 4.6 mm, 5 μ), using acetonitrile: 20mM phosphate buffer (pH 3.0) (60:40 %, v/v) as a mobile phase at a flow rate of 1 mL/min. The detection was performed at 258 nm. The developed method was further validated as per ICH Q2 (R1) guidelines.Keywords
Telmisartan, Amlodipine Besylate, Hydrochlorthiazide, RP-HPLC, Analytical Method Validation.References
- Wan, X., P. Ma, and X. Zhang, A promising choice in hypertension treatment: Fixed-dose combinations. Asian Journal of Pharmaceutical Sciences, 2014,9(1): p. 1-7.
- Kondawar, M., et al., UV spectrophotometric estimation of amlodipine besylate and telmisartan in bulk drug and dosage form by multiwavelength analysis. Int. J Chem Tech Res, 2011. 3: p.1274-8.
- Kranthi, M. and A. Srinivas, Analytical Method Development and Validation and Force Degradation Studies for Simultaneous Estimation of Amlodipine Besylate and Telmisartan in Tablet Dosage Form by using RP-HPLC. International Journal of Pharmaceutical and Phytopharmacological Research, 2017,4(1): p.2-7.
- Thomas, A.B., et al., Simultaneous spectrophotometric estimation of amlodipine besylate and telmisartan in tablet dosage form. Int J Pharm Tech Res, 2010, 2: p. 1334-1341.
- Vekariya, N., et al., Application of TLC-densitometry method for simultaneous estimation of telmisartan and amlodipine besylate in pharmaceutical dosage form. Int. J. Pharm. Res, 2009, 1(4): p.1644-1649.
- Shah, N., et al., Development and validation of a HPTLC method for the simultaneous estimation of telmisartan and hydrochlorothiazide in tablet dosage form. Indian Journal of Pharmaceutical Sciences, 2007,69(2): p. 202.
- Wankhede, S.B., et al., RP-HPLC method for simultaneous estimation of telmisartan and hydrochlorothiazide in tablet dosage form. Indian journal of pharmaceutical sciences, 2007, 69(2): p.298.
- Gangola, R., S. Kaushik, and P. Sharma, Spectrophotometric simultaneous determination of hydrochlorothiazide and telmisartan in combined dosage form. Journal of Applied Pharmaceutical Science, 2011, 1(1): p. 46.
- Kavitha, J., et al., Development and validation of RP-HPLC method for simultaneous estimation of telmisartan and hydrochlorothiazide in tablets: its application to routine quality control analysis. Int J Pharm Pharm Sci, 2011, 3: p. 113-5.
- Rane, V., J. Sangshetti, and D. Shinde, Simultaneous highperformance liquid chromatographic determination of telmisartan and hydrochlorothiazide in pharmaceutical preparation. Journal of Chromatographic Science, 2008. 46(10): p. 887-891.
- Bhatia, N., et al., Development and validation of spectrophotometric and ion pair chromatographic techniques for estimation of telmisartan and hydrochlorothiazide. 2010.
- Maheswari, R., et al., Simultaneous estimation of telmisartan and hydrochlorothiazide in tablet dosage form by HPTLC method.Asian Journal of Chemistry, 2007, 19(7): p. 5582.
- Nalwade, S., et al., Rapid simultaneous determination of telmisartan, amlodipine besylate and hydrochlorothiazide in a combined poly pill dosage form by stability-indicating ultraperformance liquid chromatography. Scientia Pharmaceutica, 2011, 79(1): p. 69-84.
- Sinojiya, R.S., et al., Development and Validation of RP-HPLC Method for the Simultaneous Determination of Telmisartan, Amlodipine Besylate and Hydrochlorothiazide in a Tablet Dosage Form. Journal of Pharmacy Research Vol, 2012,5(8): p. 41544157.
- Mhaske, R., et al., RP-HPLC method for simultaneous determination of amlodipine Besylate, Valsartan, Telmisartan, Hydrochlorothiazide and Chlorthalidone: application to commercially available drug products. International Journal of Pharmaceutical Sciences and Research, 2012,3(1): p. 141.
- Validation of Analytical Procedures: Text and Methodology, Q2R1, International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use: ICH Harmonized Triplicate Guidelines 2005.
- Development and Validation of RP-HPLC Method for Simultaneous Estimation of Ezetimibe and Glimepiride in Tablet Dosage Form
Abstract Views :182 |
PDF Views:0
Authors
Affiliations
1 MET’s Institute of Pharmacy, Bhujbal Knowledge City, Adgaon, Nashik – 42200, IN
1 MET’s Institute of Pharmacy, Bhujbal Knowledge City, Adgaon, Nashik – 42200, IN
Source
Asian Journal of Pharmaceutical Analysis, Vol 7, No 3 (2017), Pagination: 185-188Abstract
A simple, accurate and precise RP-HPLC method was developed and validated for simultaneous estimation of glimepiride (GLM) and ezetimibe (EZE) in tablet dosage form. Both drugs were separated on C18 Phenomenex column (250 × 4.6 mm, 5 μ) using methanol: 20mM potassium phosphate buffer (pH 3.00) (80: 20 % v/v) at flow rate of 1 mL/min. All eluents were detected at 230 nm. GLM and EZE were eluted at 5.292 and 4.183 min, respectively. The method was linear in the range of 2-10 μg/mL and 20-100 μg/mL for GLM and EZE, respectively. The developed method was further validated as per ICH Q2(R1) guidelines and applied successfully for the quantitation of tablet dosage form.Keywords
Ezetimibe and Glimepiride, RP-HPLC, Analytical Method Validation.References
- Anthony C Moffat, M.David Osselton and Barian Widdop, Clarke's Analysis of Drug and Poision.3rd edition 2: p.1080.
- Indian Pharmacolopoeia. (2014). 7 ed: Indian Pharmacopoeial Commission 2014.
- Saito, I., et al., A randomized, double-blind, placebo-controlled study of the effect of Ezetimibe on glucose metabolism in subjects with type 2 diabetes mellitus and hypercholesterolemia. Lipids in Health and Disease, 2015,14(1): p. 40.
- B.Siddartha and Radhika Malipelli, Simultaneous Estimation and Validation of Ezetimibe and Glimepride in Bulk and Pharmaceutical Dosage Form By RP-HPLC International journal of Research and Development in Pharmacy and Life Sciences, 2014, 3(6)(3): p. 1280-1286.
- T. Sonwjanya Jyothi, P.Nagaraju, Simultaneous Quantification and Validation of Glimepride and Ezetimibe By RP-HPLC in Bulk and Pharamcetutical Dosage Form, 2(3): p.1-5.
- Sudheer Kumar N, Shilpa K, Ajitha A , Uma Maheswara Rao V Method Development and Validation of Simultaneous Estimation of Ezetimibe and Glimepiride By RP-HPLC International journal of Pharmaceutical Research and Analysis, 2016, 6(1): p.47-52.
- Pavani, P., A. Srilekha, and B. Sreedhar, Stability indicating RPHPLC method development and validation for simultaneous estimation of glimepiride and ezetimibe in bulk and tablet dosage form. International Journal of Pharmaceutical Sciences and Research, 2015, 6(3): p. 1066.
- Hanifa Begum, S.H. Rizwan, Khaled Bin Sayeed Stability Indicating Analytical Method Development and Validation For Estimation of Ezetimibe and Glimepiride Using RP- HPLC Method in Bulk Drugs and Marketed Fromulation.Indo American Journal of Pharmaceutical Research, 2014,Vol 4, (Issue 10).
- Validation of Analytical Procedures: Text and Methodology, Q2R1, International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use: ICH Harmonized Triplicate Guidelines 2005.
- Predicting the Anti-Inflammatory Activity of Novel 5-Phenylsulfamoyl-2-(2-Nitroxy) (Acetoxy) Benzoic Acid Derivatives using 2D and 3D-QSAR (kNN-MFA) Analysis
Abstract Views :448 |
PDF Views:0
Authors
Affiliations
1 Department of Pharmaceutical Chemistry, Bhujbal Knowledge City, MET’S IOP, Adgaon, Nashik-422003, IN
1 Department of Pharmaceutical Chemistry, Bhujbal Knowledge City, MET’S IOP, Adgaon, Nashik-422003, IN
Source
Asian Journal of Research in Pharmaceutical Sciences, Vol 7, No 4 (2017), Pagination: 227-234Abstract
The quantitative structure–activity relationship (QSAR) analyses were carried out for a series of new side chain modified 5-phenylsulfamoyl-2-(2-nitroxy) (acetoxy) benzoic acid derivatives to find out the structural requirements of their anti-inflammatory activities. The statistically significant best 2D QSAR models for anti-inflammatory activity having correlation coefficient (r2) = 0.897 and cross validated squared correlation coefficient (q2) = 0.701 with external predictive ability (pred_r2) = 0.390 were developed by multiple linear regression coupled with genetic algorithm (GA–MLR) and stepwise (SW–MLR) forward algorithm, respectively. The results of the present study may be useful on the designing of more potent analogues as antimalarial agents.Keywords
QSAR, 5-Phenylsulfamoyl-2-(2-Nitroxy) (Acetoxy) Benzoic Acid, Anti-Inflammatory, MLR, Genetic Algorithm.References
- H. Abadi, et al. (2005), Synthesis of novel 4-substituted-7-trifluoromethylquinoline derivatives with nitric oxide releasing properties and their evaluation as analgesic and anti-inflammatory agents, Bioorganic and Medicinal Chemistry , 13, pp. 5759–5765.
- U. K. Bandarage, et al. (2000) Nitrosothiol esters of diclofenac synthesis and pharmacological characterization as gastrointestinal-sparing prodrugs, Journal of Medicinal Chemistry, 43, pp. 4005-16.
- S. V. Bhandari, et al. (2009) Design, synthesis and pharmacological screening of novel nitric oxide donors containing 1,5-diarylpyrazolin-3-one as nontoxic NSAIDs, European Journal of Medicinal Chemistry, 44, pp.4622–4636
- Ajmani, S., Jadhav, K., and Kulkarni, S. (2006), Three-dimensional QSAR using the k-nearest neighbor method and its interpretation. Journal of chemical information and modeling, 46, pp. 24-31.
- BOLTON, S. and BON, C. (2004), Pharmaceutical Statistics- Practical and Clinical Application 4th Ed. New York, USA: Marcel Dekker Inc.
- C. Cena, et al. (2003) Anti-inflammatory, Gastro sparing, and Antiplatelet Properties of New NO-Donor Esters of Aspirin, Journal of Medicinal Chemistry, 46, pp. 747- 54.
- M. A. Chowdhury, et al. (2010), Celecoxib analogs possessing a N-(4-nitrooxybutyl) piperidin-4-yl or N-(4- nitrooxybutyl)-1,2,3,6-tetrahydropyridin-4-yl nitric oxide donor moiety: Synthesis, biological evaluation and nitric oxide release studies, Bioorganic and Medicinal Chemistry Letters , 20, pp.1324–1329
- M. A. Chowdhury, et al. (2008), Synthesis of new 4-[2-(4-methyl (amino) sulfonylphenyl)-5-trifluoromethyl-2H-pyrazol-3-yl]-1, 2, 3, 6-tetrahydropyridines: A search for novel nitric oxide donor anti-inflammatory agents, Bioorganic and Medicinal Chemistry, 16, pp.8882–88
- B. C. Daniel, et al. (2008), Non-steroidal Anti-inflammatory Agents – Benefits and New Developments for Cancer Pain, Supportive Oncology, pp. 18-22.
- J. E Downing, et a.l (2005) Gastric and thymic assay of acute oral treatment of rats with nitric oxide esters of ibuprofen or indomethacin, Biochem. Biophys. Res. Commun.
- O. O. Fadeyi, et al (2004) Antipyretic, analgesic, anti-inflammatory and cytotoxic effects of four derivatives of salicylic acid and anthranilic acid in mice and rats, African Journal of Biotechnology, 3(8), pp. 426-431
- S. Fiorucci, J. L. Wallace, R. N. Dubois, et al.(2000) New anti-inflammatory agents: NO-NSAIDS and COX-2 inhibitors. International conference on “Advances in Prostaglandin and Leukotriene Research: Basic Science and New Clinical Applications”, June (4-8), pp. 2.
- S. Fioruccia, et al. (2007), NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: What lies beyond the horizon, Digestive and Liver Disease, 39, pp. 1043–1051.
- Objective Monitoring of Cardiovascular Biomarkers Using Artificial Intelligence (AI)
Abstract Views :67 |
PDF Views:0
Authors
Sahil Mahajan
1,
Heemani Dave
1,
Santosh Bothe
2,
Debarshikar Mahpatra
3,
Sandeep Sonawane
1,
Sanjay Kshirsagar
1,
Santosh Chhajed
1
Affiliations
1 METs Institute of Pharmacy, Bhujbal Knowledge City, Affiliated to SPPU Pune University, Nashik, Maharashtra, IN
2 IEDC SVKM’s NMIMS University, Shirpur, Dist. Dhule, Maharashtra, IN
3 Department of Pharmaceutical Chemistry, Dadasaheb Balpande College of Pharmacy, Nagpur, Maharashtra, IN
1 METs Institute of Pharmacy, Bhujbal Knowledge City, Affiliated to SPPU Pune University, Nashik, Maharashtra, IN
2 IEDC SVKM’s NMIMS University, Shirpur, Dist. Dhule, Maharashtra, IN
3 Department of Pharmaceutical Chemistry, Dadasaheb Balpande College of Pharmacy, Nagpur, Maharashtra, IN
Source
Asian Journal of Pharmaceutical Research, Vol 12, No 3 (2022), Pagination: 229 - 234Abstract
Different CVDs (CVD) are the leading wreak of mortality and disability worldwide. The pathology of CVD is complex; multiple biological pathways have been involved. Biomarkers act as a measure of usual or pathogenic biological processes. They play a significant part in the definition, prognostication, and decision-making with respect to the treatment of cardiovascular events. Inthis article, we had summarized key biomarkers which are essential to predict CVDs. We had studied prevalence, pattern of expression of biomarkers (salivary, inflammatory, oxidative stress, chemokines, antioxidants, genetic, etc.), its measurable impact, benefits of early detection and its scope. A Considerable number of deaths due to cardiovascular diseases (CVDs) can be attributed to tobacco smoking and it rises the precarious of deathfrom coronary heart disease and cerebrovascular diseases. Cytokines which is categorized into pro inflammatory and anti-inflammatory take part in as biomarkers in CHD, MI, HF. Troponin, growth differentiation factor-15(GDF-15), C-reactive protein, fibrinogen, uric acid diagnose MI and CAD. Matrix Metalloproteins, Cell Adhesion Molecules, Myeloperoxidase, Oxidative stress biomarkers, Incendiary biomarkers are useful to predict the risk of UA, MI, and HF. Increased Endothelin-1, Natriuretic peptides, copeptin, ST-2, Galectin-3, mid-regional-pro-adrenomedullin, catecholamines are used to prognosticate Heart failure. Modern technologies like Artificial Intelligence (AI), Biosensor and high-speed data communication made it possible to collect the high-resolution data in real time. The high-resolution data can be analyzed with advance Machine Learning (ML) algorithms, it will not only help to discover the disease patterns but also an real-time and objective monitoring of bio-signals can help to discover the unknown patterns linked with CVD.
Keywords
CVDs, Biomarkers, Artificial Intelligence, Machine Learning, Personalized medicine, MonitoringReferences
- Ying Huang JL. MicroRNA208 family in CVDs: therapeutic implication and potential biomarker. Journal of Physiology and Biochemistry. 2015 April; 71: p. 479-486.
- Duvall WL. CVDs in Women. 2003 Oct.: p. 293-305.
- Asia Pacific Cohort Studies Collaboration, Clinical Trials Research Unit,. Blood Pressure and CVDs in the Asia Pacific region. Journal of Hypertension. 2003 Jan; 21(4): p. 707-716.
- David S. Celermajer, Clara K Chow, EloiMarijon. CVDs in the Developing World. Journal of the American College of Cardiology. 2012 Oct.; 60(14).
- Prof. Mathias M. Müller, Andrea Griesmacher. Rational Diagnosis of CVDs.the journal of International Federation of Clinical Chemistry and Laboratory Medicine. 2003 Jul 3; 14(2): p. 95-103.
- Isaac Subirana, Montserrat Fito, Oscar Diaz, Joan Vilaet.al. Prediction of coronary disease incidence by biomarkers of inflammation, oxidation, and metabolism. Scientific Report.2018 Feb.; 8(3191).
- Yayan, Josef. Emerging families of biomarkers for coronary artery disease: inflammatory mediators. V ascular Health and Risk Management.2013 July 31; 2013(9).
- Richard Dobson, Hamish A Walker, Niki L Walker. Biomarkers in congenital heart disease. Biomarkers in Medicine. 2014 01 August; 8(7).
- DrRamu Adela, Sanjay K. Banerjee. Review Article GDF-15 as a Target and Biomarker for Diabetes and CVDs: A Translational Prospective. Journal of Diabetes Research. 2015; 2015.
- D.Gianness, M.MaltintiS., Del Ryi. Adiponectin circulating levels: A new emerging biomarker of cardiovascular risk. Pharmacological Research. 2007 December; 56(6).
- Roland R J van Kimmenade, James L Januzzi. Emerging Biomarkers in Heart Failure.Clinical Chemistry. 2012 1 January; 58(1).
- S.H. Han et.al. Adiponectin and CVDs: response to therapeutic interventions. Journal of the American College of Cardiology. 2007 6 February; 49(5).
- Evelyn Barron, Jose Lara et.al. Blood-Borne Biomarkers of Mortality Risk: Systematic Review of Cohort Studies. PLoS ONE.2015 June 3; 10(6).
- KonstantinosStellosMR,S,Kea.Plasmalevelsofstromalcell-derived factor-1 in patients with coronary artery disease. Atherosclerosis. 2011; 219(2).
- Toru Suzuki, Eduardo Bossone, Daigo Sawaki, Rolf AlexanderJanosi et.al. Biomarkers of aortic diseases. American Heart Journal.2013 Jan; 165(1).
- Wu AHB. Markers for Early Detection of Cardiac Diseases.Scandinavian Journal of Clinical and Laboratory Investigation. 2009; 65, 2005
- Suzuki T, Katoh H, Kurabayashi M, et al. Biochemical diagnosis of aortic dissection by raised concentrations of creatine kinase BB isozyme. Lancet.1997; 350(9080).
- Toru Suzuki Alessandro Distante, AntonellaZizza, SantiTrimarchi, Massimo Villani et.al. Preliminary experience with the smooth muscle troponin-like protein, calponin, as a novel biomarker for diagnosing acute aortic dissectio. European Heart Journal.2008 June; 29(11).
- Said El Shamieh SVS. Genetic biomarkers of hypertension and future challenges integrating epigenomics. Clinica Chimica Acta.2012 24 December; 414.
- Beat heartbreak forever. [Online]. [cited 2020 August 2. Available from: https://www.bhf.org.uk/informationsupport/tests/blood-tests.
- Apple JAaF. Blood Tests Detecting Heart Disease.Circulation-AHA Journals.2004; 109(3).
- LabTestsOnline.[Online].;August12,2020.
- Peter. A. Kavsak, Alan.H.B.Wu. Biomarkers for Coronary Artery Disease and Heart Failure, Contemporary Practice in Clinical Chemistry.2020 19 June; p.519-543.
- Medical News Today Online. [Online].; June 7, 2019. https://www.medicalnewstoday.com/articles/325415
- “Creatine Kinase”. Merriam-Webster.com.; Aug https://www.merriam- webster.com/dictionary/creatine%20kinase
- Britannica, T. Editors of Encyclopaedia myoglobin. Encyclopedia Britannica.14 November 2017.
- Jean P. Dzoyem, Victor Kuete, Jacobus N. Eloff. Biochemical Parameters in Toxicological Studies in Africa: Significance, Principle of Methods, Data Interpretation, and Use in Plant Screenings. Toxicology Survey of African Medical Plants, 2014; p.659-715.
- GiuseppeLippi,CamillaMattiuzzi,IvanComelli,GianfrancoCervellin
- BiochemMed(Zagreb)2013Feb;23(1):78–82.
- Bełtowski J, Jamroz A. Adrenomedullin--what do we know 10 years since its discovery? Pol J Pharmacol. 2004 Jan-Feb;56(1):5-27.
- Epaminondas Zakynthinos, Nikolitsa Pappa, Inflammatory biomarkers in coronary artery disease,
- Journal of Cardiology, Volume 53, Issue 3,2009, p.317-333.
- Xu Jun-Yan, Xiong Yu-Yan, Lu Xiao-Tong, Yang Yue-Jin, Regulation of Type 2 Immunity in Myocardial Infarction, Frontiers in Immunology, Volume 10, 2019.
- Jung M, Ma Y, Iyer RP, et al. IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation. Basic Res Cardiol. 2017;112(3):33.
- Castro Flávia, Cardoso Ana Patrícia, Gonçalves Raquel Madeira, Serre Karine, Oliveira Maria José.Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion.Frontiers in Immunology 2018;9.
- Ravi Dhingra, Ramachandran S. Vasan.Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers, Trends in Cardiovascular Medicine.2017, 27(2),p 123-133.